STAT+: Pharmalittle: An arthritis drug reduced Covid-19 death rates; impatience grows over choosing FDA commissioner
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is fairly modest. We hope to hang with Mrs. Pharmalot, catch up on our reading, and promenade with the spirited official mascot. And what about you? This remains a fine time to enjoy the great outdoors or to take a well-deserved nap. You could sign up for a Covid-19 vaccination or reach out to someone feeling isolated. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you on Tuesday, since we have an extended holiday weekend on this side of the pond. …
The U.S. has finalized a previously announced deal with Pfizer (PFE) and Moderna (MRNA) for 200 million more Covid-19 vaccine doses, which President Biden says should be enough to vaccinate every American, NBC News tells us. Biden said the federal government signed the final contracts Thursday afternoon for 100 million more doses of the Moderna vaccine and 100 million more from Pfizer and BioNTech (BNTX). Last month, Biden said he was directing the government to secure more doses on top of the 400 million ordered during the Trump administration.
Continue to STAT+ to read the full story…
